MedTrace Logo

An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes

NCT01400971 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4299

Last updated 2020-03-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to identify specific patient, physician, and health system related factors associated with the progression to a more intensive regimen from initial insulin therapy for patients with type 2 diabetes.

Conditions

  • Diabetes Mellitus, Type 2

Sponsors & Collaborators

Principal Investigators

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • United States
  • Argentina
  • Brazil
  • Canada
  • China
  • Germany
  • India
  • Israel
  • Italy
  • Japan
  • Mexico
  • Puerto Rico
  • Russia
  • Saudi Arabia
  • South Korea
  • Spain
  • Turkey (Türkiye)
  • United Arab Emirates
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01400971 on ClinicalTrials.gov